Genetically Engineered Cells (EGFRt/19-28z/IL-12 CAR T Cells) for the Treatment of Relapsed or Refractory CD19+ Hematologic Malignancies
Roswell Park Cancer Institute
Roswell Park Cancer Institute
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Fred Hutchinson Cancer Center
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
University of Wisconsin, Madison
Academic and Community Cancer Research United
Stanford University
University of Alabama at Birmingham
University of Nebraska
Rutgers, The State University of New Jersey
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
Swiss Cancer Institute
Brown University
The First Affiliated Hospital with Nanjing Medical University
Weill Medical College of Cornell University
University of Washington
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
University of Michigan Rogel Cancer Center
Barbara Ann Karmanos Cancer Institute
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
Barbara Ann Karmanos Cancer Institute
Masonic Cancer Center, University of Minnesota
OHSU Knight Cancer Institute
Vanderbilt-Ingram Cancer Center
M.D. Anderson Cancer Center
Weill Medical College of Cornell University
City of Hope Medical Center
Case Comprehensive Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Barbara Ann Karmanos Cancer Institute
M.D. Anderson Cancer Center
Lymphoma Study Association
Vanderbilt-Ingram Cancer Center
Wake Forest University Health Sciences
Ohio State University Comprehensive Cancer Center
Dartmouth-Hitchcock Medical Center
Emory University
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota